Related Experiment Videos
[Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis]
H Zwahlen1, F Quadri, G Mombelli
1Dipartimento di medicina interna, Ospedale San Giovanni, Bellinzona.
Schweizerische Medizinische Wochenschrift
|December 10, 1988
Summary
Plasma exchange shows promising results for severe Guillain-Barré polyneuritis, especially in patients with walking difficulties and respiratory failure. Early treatment within 1-2 weeks of symptom onset is recommended for optimal outcomes.
Area of Science:
- Neurology
- Immunology
Background:
- Guillain-Barré polyneuritis can have severe outcomes, with no proven effective therapies available.
- An immunologic etiology is presumed for Guillain-Barré polyneuritis, leading to the exploration of immunomodulatory treatments.
Observation:
- Three patients with severe Guillain-Barré polyneuritis, including two with acute respiratory failure and all unable to walk, were treated.
- The patients demonstrated significant and rapid improvement following plasma exchange therapy.
Findings:
- Plasma exchange treatment correlated with surprisingly good clinical improvement in patients with severe Guillain-Barré polyneuritis.
- The study suggests plasma exchange is a viable option for severe Guillain-Barré polyneuritis, particularly in cases with motor deficits.
Implications:
- Plasma exchange can be recommended for severe Guillain-Barré polyneuritis, especially in patients with inability to walk.
- Initiating plasma exchange within 1-2 weeks of disease onset may improve patient outcomes.
- Further research into immunomodulatory treatments for Guillain-Barré polyneuritis is warranted.